Breaking News Instant updates and real-time market news.

W

Wayfair

$84.93

-1.5 (-1.74%)

, AMZN

Amazon.com

$1,751.03

-1.67 (-0.10%)

10:57
11/19/19
11/19
10:57
11/19/19
10:57

Citron accuses Wayfair of lying, says shares headed to $45

Andrew Left's Citron Research issued another short report on Wayfair (W), claiming management has been lying and that the shares are headed to $45 in the near term. The online retailer in morning trading is down 3%, or $2.39, to $84.04. "After eight years operating as a public company, Wayfair has never been further from profitability as its most recent quarterly earnings release reflects the Company's largest quarterly loss while revenue growth is decelerating," Citron claims in a new report posted on its website. Further, the company issued a "complete lie" when blaming its quarterly results on "some short-term tariff related volatility," contends Citron. The firm known for its short selling also says Amazon.com (AMZN) in the past five months has launched a series on furniture commercials that highlight free delivery. If Wayfair were to have the same enterprise value as RH (RH), "the stock would immediately be trading at $46.... and this ain't no RH," writes Citron.Reference Link

W

Wayfair

$84.93

-1.5 (-1.74%)

AMZN

Amazon.com

$1,751.03

-1.67 (-0.10%)

RH

RH

$181.50

-6.08 (-3.24%)

  • 19

    Nov

  • 20

    Nov

  • 19

    Dec

W Wayfair
$84.93

-1.5 (-1.74%)

11/12/19
LEHM
11/12/19
INITIATION
Target $76
LEHM
Underweight
Wayfair initiated with an Underweight at Barclays
Barclays analyst Adrienne Yih initiated coverage of Wayfair with an Underweight rating and $76 price target. The analyst points to the company's slowing sales growth with tariff uncertainty impacting pricing, the need for continued investment in human capital, advertising, and infrastructure, and the erosion of profitability given its "variable cost model".
11/18/19
SPHN
11/18/19
NO CHANGE
Target $80
SPHN
Overweight
Aaron's Progressive no longer listed on Wayfair site as partner, says Stephens
Stephens analyst Vincent Caintic said his checks revealed that Progressive, a unit of Aaron's (AAN), is no longer listed as one of the four "partners" of WayFair Financing on Wayfair's (W) website as it is his understanding that Zibbys and Affirm displaced Progressive at the furniture company. While he thinks it is still possible that Progressive may return as a financing partner in the future and believes there is significant white space in retail partnerships for all rent-to-own players to succeed, the news makes him incrementally more positive on Curo Group (CURO) given their 40% ownership stake in Zibbys, Caintic tells investors. He keeps an Overweight rating and $80 price target on Aaron's shares and called the stock his top pick coming out of the firm's Investment Conference.
11/11/19
ARGS
11/11/19
UPGRADE
Target $96
ARGS
Buy
Wayfair upgraded to Buy from Hold at Argus
Argus analyst Jim Kelleher upgraded Wayfair to Buy from Hold with a $96 price target. The analyst says the recent "sharp pullback" in the stock price offers a favorable entry point, with added benefits expected if U.S. and China can reach a "phase 1" trade agreement, since about 60% of its products are made in China. Kelleher further noted that while Wayfair's Q3 saw larger than expected loss and weak revenue guidance, its business model remains "fundamentally strong", adding that its stock trades at a deep discount relative to other major online retailers.
11/11/19
11/11/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wayfair (W) upgraded to Buy from Hold at Argus with analyst Jim Kelleher saying the recent "sharp pullback" in the stock price offers a favorable entry point, with added benefits expected if U.S. and China can reach a "phase 1" trade agreement, since about 60% of its products are made in China. 2. Q2 Holdings (QTWO) upgraded to Buy from Neutral at BTIG with analyst Mark Palmer saying the recent pullback in the stock price offers an attractive entry point given the company's takeout target potential. 3. Plug Power (PLUG) upgraded to Buy from Neutral at Roth Capital with analyst Craig Irwin citing visibility for the company continuing on impressive growth trajectory, outlook for record revenue and EBITDA in Q4, and material EBITDA profitability in 2020. 4. Alliance Data (ADS) upgraded to Outperform from Perform at Oppenheimer with analyst Dominick Gabriele saying he sees the card services segment net of corporate drag as worth at least $119 using a 2.95x P/TBV multiple, and total Alliance Data including LoyaltyOne could be worth $131. 5. Oshkosh (OSK) upgraded to Buy from Neutral at Buckingham with analyst Neil Frohnapple saying his firm recently completed its monthly equipment rental rate momentum survey and says that overall, 52% of contacts surveyed noted that rental rates were above their expectations in the month of October. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AMZN Amazon.com
$1,751.03

-1.67 (-0.10%)

11/13/19
NOMU
11/13/19
NO CHANGE
Target $42
NOMU
Neutral
Nike ending direct Amazon sales positive for Dick's, says Nomura Instinet
Nomura Instinet analyst Michael Baker says Nike's (NKE) decision to stop selling product directly to Amazon (AMZN), as reported this morning by Bloomberg, should be positive for Dick's Sporting Goods (DKS). Nike product will still be available on Amazon through its third-party market place, so the good for Dick's "is only modest," Baker tells investors in a research note titled "DKS Winning Online." The analyst believes Dick's is one of Nike's most valuable partners. The company accounts for about 6.6% of Nike's North American sales and 9.6% of its North American wholesale sales, and the penetration has been growing, contends Baker. This makes Dick's Nike's second-biggest wholesale partner, says the analyst, how keeps a Neutral rating on Dick's with a $42 price target.
11/15/19
JPMS
11/15/19
NO CHANGE
JPMS
Overweight
JPMorgan adds Lyft to list of top Internet picks
Earlier, JPMorgan analyst Doug Anmuth added Lyft (LYFT) to his list of top picks in the internet sector following third quarter earnings, saying the ride-hailing giant reported "significantly" better than expected revenue and EBITDA as it continues to take share of an increasingly rational U.S. rideshare market, thereby accelerating its path to profitability. Anmuth said that Lyft, which joins Facebook (FB), Amazon (AMZN), and Netflix (NFLX) in his top picks in the sector, also reiterated its expectation for consolidated EBITDA profit by the fourth quarter of 2021, though he continues to believe core rideshare can be profitable "well before that," likely sometime in 2020. The analyst, who has an Overweight rating on Lyft, noted that he removed Twitter (TWTR) and IAC/InterActive (IAC) from his top picks.
11/18/19
DADA
11/18/19
INITIATION
Target $55
DADA
Neutral
Crowdstrike valuation appropriately balances upside potential, says DA Davidson
As reported earlier, DA Davidson Andrew Nowinski initiated coverage of Crowdstrike (CRWD) with a Neutral rating and $55 price target, saying the company is generating "unmatched" ARR growth, driven by sustainable, competitive advantages from a cloud-based platform. Nowinski said he believes the Amazon Web services (AMZN) partnership is seeing increasing momentum and the company has the potential to expand margins longer-term. The analyst noted, however, that he believes the current valuation appropriately balances the upside potential from these drivers.
11/19/19
WBLR
11/19/19
NO CHANGE
WBLR
Outperform
Kornit sales beat when adjusting for Amazon warrants, says William Blair
William Blair analyst Brian Drab says Kornit Digital (KRNT) reported "another impressive quarter." Kornit's Q3 results were ahead of expectations, contrary to the negative headlines immediately following the report, which were again based on misinterpretation of results given the impact of Amazon warrants (AMZN), Drab tells investors in a post-earnings research note. Adjusting correctly for the warrants, the company's Q3 revenue increased 27%, to $49.7M, ahead of the consensus estimate of $48.7M, adds the analyst. He expects Kornit to continue to generate greater than 20% revenue growth and keeps an Outperform rating on the shares.
RH RH
$181.50

-6.08 (-3.24%)

09/16/19
LOOP
09/16/19
NO CHANGE
Target $190
LOOP
Buy
RH price target raised to $190 from $180 at Loop Capital
Loop Capital analyst Anthony Chukumba raised his price target on RH to $190 and kept his Buy rating after the company's completed convertible note offering last week. The analyst says he is impressed with RH's ability to issue debt without any cash interest cost, which highlights investors' confidence in the company's long-term potential.
11/12/19
LEHM
11/12/19
INITIATION
Target $198
LEHM
Overweight
RH initiated with an Overweight at Barclays
Barclays analyst Adrienne Yih initiated coverage of RH with an Overweight rating and $198 price target. The analyst is positive on the company's business model that is already more than 90% direct-to-consumer and the strength of its brand limiting discounting. Yih adds that RH is benefiting from the shift in the inventory model away from high "in-stock" levels to a more customizable, build-to-order inventory model.
10/08/19
WOLF
10/08/19
INITIATION
Target $197
WOLF
Peer Perform
RH assumed with a Peer Perform rating at Wolfe Research
Wolfe Research analyst Chris Bottiglieri assumed coverage of RH with a Peer Perform rating and $197 price target.
09/19/19
WELS
09/19/19
NO CHANGE
Target $195
WELS
Outperform
RH price target raised to $195 from $175 at Wells Fargo
Wells Fargo analyst Zachary Fadem raised his price target for RH to $195 from $175 to reflect the closing of the company's $350M convertible note offering. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

SPT

Sprout Social

20:34
12/12/19
12/12
20:34
12/12/19
20:34
Syndicate
Sprout Social 8.824M share IPO priced at $17.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

SCHW

Charles Schwab

$51.08

1.48 (2.98%)

20:16
12/12/19
12/12
20:16
12/12/19
20:16
Upgrade
Charles Schwab rating change at Keefe Bruyette »

Charles Schwab upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$84.00

-2.97 (-3.41%)

20:08
12/12/19
12/12
20:08
12/12/19
20:08
Upgrade
Bluebird Bio rating change at Oppenheimer »

Bluebird Bio upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQST

Aquestive Therapeutics

$6.73

-0.97 (-12.60%)

20:07
12/12/19
12/12
20:07
12/12/19
20:07
Syndicate
Aquestive Therapeutics 7M share Secondary priced at $5.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

BY

Byline Bancorp

$18.95

0.54 (2.93%)

19:56
12/12/19
12/12
19:56
12/12/19
19:56
Hot Stocks
Byline Bancorp initiates 3c per share cash dividend »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

NXGN

NextGen Healthcare

$16.83

-1.28 (-7.07%)

19:08
12/12/19
12/12
19:08
12/12/19
19:08
Downgrade
NextGen Healthcare rating change at Cantor Fitzgerald »

NextGen Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AMOT

Allied Motion

$46.79

0.81 (1.76%)

18:57
12/12/19
12/12
18:57
12/12/19
18:57
Hot Stocks
Allied Motion CEO sells 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LILA

Liberty Latin America

$17.56

0.32 (1.86%)

, DISCA

Discovery

$32.36

0.28 (0.87%)

18:54
12/12/19
12/12
18:54
12/12/19
18:54
Hot Stocks
Liberty Latin America says Dr. John Malone retires from board »

Liberty Latin America…

LILA

Liberty Latin America

$17.56

0.32 (1.86%)

DISCA

Discovery

$32.36

0.28 (0.87%)

LGF.A

Lionsgate

$9.99

0.65 (6.96%)

LGF.B

Lionsgate

$9.35

0.7 (8.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOCPY

Hoya Corp.

$0.00

(0.00%)

, TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

18:43
12/12/19
12/12
18:43
12/12/19
18:43
Hot Stocks
Hoya to offer JPY12,900 per share in tender offer for Toshiba unit NuFlare »

Hoya Corporation (HOCPY)…

HOCPY

Hoya Corp.

$0.00

(0.00%)

TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

TOSYY

Toshiba

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

ADBE

Adobe

$305.76

2.01 (0.66%)

, SRPT

Sarepta

$100.39

-1.15 (-1.13%)

18:42
12/12/19
12/12
18:42
12/12/19
18:42
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Adobe…

ADBE

Adobe

$305.76

2.01 (0.66%)

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

DDOG

Datadog

$35.75

0.23 (0.65%)

RIG

Transocean

$5.94

0.28 (4.95%)

TPR

Tapestry

$26.35

0.515 (1.99%)

GTIM

Good Times Restaurants

$1.71

0.14 (8.92%)

ORCL

Oracle

$56.47

0.16 (0.28%)

AVGO

Broadcom

$327.39

7.53 (2.35%)

COST

Costco

$297.50

2.28 (0.77%)

CNC

Centene

$58.52

-0.13 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 23

    Jan

  • 23

    Mar

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

18:40
12/12/19
12/12
18:40
12/12/19
18:40
Hot Stocks
Breaking Hot Stocks news story on Sarepta »

Sarepta up 28.5% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHR

Phreesia

$28.67

0.1 (0.35%)

18:38
12/12/19
12/12
18:38
12/12/19
18:38
Syndicate
Phreesia 6.75M share Secondary priced at $26.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

18:31
12/12/19
12/12
18:31
12/12/19
18:31
Hot Stocks
Breaking Hot Stocks news story on Sarepta »

Sarepta to resume trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

18:25
12/12/19
12/12
18:25
12/12/19
18:25
Hot Stocks
Adobe CEO: We are not overly concerned with the trade war with China »

Comment from interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 23

    Jan

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

18:20
12/12/19
12/12
18:20
12/12/19
18:20
Hot Stocks
Sarepta announces FDA approval of VYONDYS 53 injection to treat DMD »

Sarepta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,760.44

11.33 (0.65%)

18:11
12/12/19
12/12
18:11
12/12/19
18:11
Hot Stocks
Amazon orders fourth season of 'The Marvelous Mrs. Maisel' »

Amazon Studios announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHAI

OHA Investment

$1.28

(0.00%)

, PTMN

Portman Ridge Finance

$2.04

(0.00%)

18:10
12/12/19
12/12
18:10
12/12/19
18:10
Hot Stocks
OHA Investment obtains stockholder approval of Portman Ridge deal »

OHA Investment…

OHAI

OHA Investment

$1.28

(0.00%)

PTMN

Portman Ridge Finance

$2.04

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCT

Oncternal Therapeutics

$4.62

0.05 (1.09%)

18:05
12/12/19
12/12
18:05
12/12/19
18:05
Hot Stocks
Oncternal presents interim data from Phase 1b clinical study of cirmtuzumab »

Oncternal Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZN

Horizon Global

$3.49

0.14 (4.18%)

18:03
12/12/19
12/12
18:03
12/12/19
18:03
Hot Stocks
Horizon Global CFO Jamie Pierson steps down »

Horizon Global announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.47

0.16 (0.28%)

18:03
12/12/19
12/12
18:03
12/12/19
18:03
Hot Stocks
Oracle CEO Catz says expects momentum in 2H20 to carry into FY21 »

Says feels "very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

18:00
12/12/19
12/12
18:00
12/12/19
18:00
Hot Stocks
Breaking Hot Stocks news story on Sarepta »

Sarepta trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.47

0.16 (0.28%)

17:52
12/12/19
12/12
17:52
12/12/19
17:52
Hot Stocks
Oracle's Ellison says 'we have no plans for having a second CEO' »

Says there won't be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NLNK

NewLink Genetics

$1.61

-0.015 (-0.93%)

, EVRC

Evercel, Inc

$0.00

(0.00%)

17:41
12/12/19
12/12
17:41
12/12/19
17:41
Hot Stocks
NewLink Genetics advances over 11% after Evercel discloses rejected offer »

Shares of NewLink…

NLNK

NewLink Genetics

$1.61

-0.015 (-0.93%)

EVRC

Evercel, Inc

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVRC

Evercel, Inc

$0.00

(0.00%)

, NLNK

NewLink Genetics

$1.61

-0.015 (-0.93%)

17:36
12/12/19
12/12
17:36
12/12/19
17:36
Hot Stocks
Evercel announces rejected offer to acquire NewLink Genetics »

Evercel (EVRC) has made…

EVRC

Evercel, Inc

$0.00

(0.00%)

NLNK

NewLink Genetics

$1.61

-0.015 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXRX

Baudax Bio

$6.30

0.225 (3.70%)

17:34
12/12/19
12/12
17:34
12/12/19
17:34
Hot Stocks
Corsair Capital reports 8.77% passive stake in Baudax Bio »

Corsair Capital disclosed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.